홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Hydrochloric Acid → 4-Vinylsulfonyl-morpholine

HRID 272550
인쇄

반응식

HRID 272550 반응식
C1C2[C:10]3=[CH:12]C4C=CC(C(N)=O)=[CH:17][C:18]=4[N:9]3CC=CC=2C=CC=1.C1C2C3=CC4C=C[C:37]([C:40](O)=O)=CC=4N3CC=CC=2C=CC=1.[OH-:43].[Na+].Cl.C(Cl)(=O)C(Cl)=O.CCN(P1(N(C)CCCN1C)=NC(C)(C)C)CC.CN[S:72](NC)(=[O:74])=[O:73]>C(Cl)Cl.CO.C1COCC1>[CH:37]([S:72]([N:9]1[CH2:10][CH2:12][O:43][CH2:17][CH2:18]1)(=[O:74])=[O:73])=[CH2:40]
참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트

참가 물질

10

반응물 7

HCID 313Hydrochloric Acid2회HCID 14798Sodium HydroxideHCID 65578Oxalyl chlorideHCID 89736N,N'-DimethylsulfamideHCID 35138512-((1,1-Dimethylethyl)imino)-N,N-diethylhexahydro-1,3-dimethyl-2lambda5-1,3,2-diazaphosphorin-2-amineHCID 666396797H-indolo[2,1-a][2]benzazepine-10-carboxylic acid
HCID 66639690
7H-indolo[2,1-a][2]benzazepine-10-carboxamide

생성물 1

HCID 159145184-Vinylsulfonyl-morpholine수율 68%

시약·촉매·용매 2

HCID 6344Dichloromethane용매2회HCID 21899815MeOH tetrahydrofuran용매

반응 조건

온도
22 °C

실험 절차

7H-Indolo[2,1-a][2]benzazepine-10-carboxamide, 13-cyclohexyl-N-[(dimethylamino)sulfonyl]-6-(4-morpholinylsulfonyl)-. To a solution of 7H-Indolo[2,1-a][2]benzazepine-10-carboxylic acid, 13-cyclohexyl-6-(4-morpholinylsulfonyl)-, methyl ester (60 mg, 0.12 mmol) in 1:1 MeOH/THF (2.0 mL) was added 1M NaOH (2.0 mL). The resulting mixture was stirred at 22° C. for 16 hr. 1M HCl (15 mL) was added and the aqueous layer was extracted with CHCl3 (2×15 mL). The organic phase was dried over Na2SO4, filtered, and concentrated under reduced pressure to afford a white solid. This solid was dissolved in CH2Cl2 (1.0 mL) and 2M oxalyl chloride (0.24 mL) in CH2Cl2 was added. This solution was stirred at 22° C. for 2 hr and concentrated under reduced pressure. The resulting yellow oil was redissolved in CH2Cl2 (1.0 mL); BEMP (0.14, 0.47 mmol) and dimethylsulfamide (59 mg, 0.47 mmol) were added. The resulting mixture was allowed to stir at 22° C. for 6 hr. 1M HCl (15 mL) was added and the aqueous layer was extracted with CHCl3 (2×30 mL). The organic phase was concentrated under reduced pressure. This oil was purified by reverse-phase prep HPLC to afford the title compound (50 mg, 68%) as a yellow paste. MS m/z 613 (MH+). 1H NMR (300 MHz, CDCl3) δ ppm 1.18-1.70 (m, 5H), 1.77 (m, 2H), 1.87-2.16 (m, 3H), 2.88 (m, 1H), 3.08 (s, 6H), 3.93 (s, 3H), 4.18 (broad m, 1H), 5.67 (broad m, 1H), 7.38 (s, 1H), 7.47 (m, 2H), 7.51 (dd, J=7.6, 8.4 Hz ,1H), 7.61 (d, J=7.6 Hz, 1H), 7.75 (d, J=8.4 Hz, 1H), 7.87 (d, J=8.4 Hz, 1H), 8.31 (s, 1H).

후처리

  1. extractionthe aqueous layer was extracted with CHCl3 (2×15 mL)
  2. dry with materialThe organic phase was dried over Na2SO4
  3. filtrationfiltered
  4. concentrationconcentrated under reduced pressure
  5. customto afford a white solid
  6. stirringThis solution was stirred at 22° C. for 2 hr
  7. concentrationconcentrated under reduced pressure
  8. dissolutionThe resulting yellow oil was redissolved in CH2Cl2 (1.0 mL)
  9. stirringto stir at 22° C. for 6 hr
  10. extractionthe aqueous layer was extracted with CHCl3 (2×30 mL)
  11. concentrationThe organic phase was concentrated under reduced pressure
  12. customThis oil was purified by reverse-phase prep HPLC

출처 및 근거

ORD 기록
ord-0b45743fafd94f049f9792fd08bba93c
출처 데이터셋
uspto-grants-2008_11
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07456167B2

반응 노트

이 페이지에서참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트